There are claims, ranging from anecdotal reports to experimental research, that cannabis and its derivative compounds have medicinal use for diabetes.
SGLT2 Inhibitors 2016: Year-End News Roundup
SGLT2 inhibitors made diabetes headlines this year by gaining FDA approval for cardiovascular indication. We highlight this news and more for 2016.
Cardiovascular Effect of an SGLT2i: Case Study
A 68-year-old man with long-standing hypertension, ischemic heart disease, obesity, T2DM, & rheumatoid arthritis was treated with an SGLT2 inhibitor.
Chocolate and Type 2 Diabetes: a Healthy Habit?
Compounds in cocoa and chocolate have known cardiovascular benefits. Could habitual chocolate intake lower the risk of type 2 diabetes as well?
Fertility Therapies & Diabetes Risk in Offspring
Researchers linked several national registries & the Danish Infertility Cohort to find data on women with infertility problems between 1963 and 2011.
AHA 2016: Obesity Paradox in Heart Failure
Does the obesity paradox exist in heart failure? What roles do ejection fraction and type 2 diabetes & acute decompensated heart failure play?
Interesting Endo: Reproductive and Adrenal Health
Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.
Bariatric Surgery: Effects on CV Health, Diabetes
Researchers investigated the impact of bariatric surgery on cardiovascular health & diabetes, as well as statin therapy & visceral adipose tissue.
CV Risks and Diabetes: Puerto Rican Population
Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.
Safety of Closed-Loop Insulin Delivery System
Dr. Bobby Lazzara reviews the safety of a hybrid closed-loop insulin delivery system for patients with type 1 diabetes in a real-world setting.
Metformin: Cardioprotective in Type 1 Diabetes?
Can metformin’s cardioprotective effect also benefit patients with type 1 diabetes? Dr. Bobby Lazzara discusses a small study of 23 patients.
By clicking Accept, you agree to become a member of the UBM Medica Community.